|Articles|February 25, 2020
Challenging Microbial Sanitization of a Liquid Chromatography System
Author(s)Bio-Rad, Chelsea Pratt, PhD
To ensure that no contaminating or hazardous residual components remain after protein purification during biologic development, additional sanitization steps may be required for the instrumentation utilized during these processes.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
Charles River Incubator Cohort to Accelerate CGT Development
2
How Mitigation and Maintenance Protect Against Future Risk
3
GSK and Oxford BioTherapeutics Drive Antibody-Based Cancer Drug Discovery at Industry Scale
4
FDA Decision Accelerates Rare Disease Gene Therapy Regulatory Pathways
5
